Literature DB >> 2722941

Total replacement of the hip for avascular necrosis in sickle cell disease.

H J Clarke1, R H Jinnah, A F Brooker, J D Michaelson.   

Abstract

Total hip replacement was performed in 27 hips of patients who had sickle cell anaemia with avascular necrosis of the femoral head. The disease was bilateral in 11 patients. Considerable medical problems were encountered although most of the patients had exchange transfusion before surgery (86%), which prevented postoperative sickle cell crises in all but two cases. At the primary operation hard sclerotic bone was seen in nine femora with complete obliteration of the femoral canal. There were four femoral fractures, three following perforation of the shaft due to this hard bone. There was a very high morbidity due to loosening in both cemented and uncemented prostheses. With a rate of 59% over a cumulative 5.5 year period, revision was being performed at an average of only 43 months. Surgeons should be aware of these problems.

Entities:  

Mesh:

Year:  1989        PMID: 2722941     DOI: 10.1302/0301-620X.71B3.2722941

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  14 in total

1.  SAS weekly rounds: avascular necrosis.

Authors:  Thomas W Hamilton; Susan M Goodman; Mark Figgie
Journal:  HSS J       Date:  2009-03-18

Review 2.  Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management.

Authors:  Samir K Ballas; Muge R Kesen; Morton F Goldberg; Gerard A Lutty; Carlton Dampier; Ifeyinwa Osunkwo; Winfred C Wang; Carolyn Hoppe; Ward Hagar; Deepika S Darbari; Punam Malik
Journal:  ScientificWorldJournal       Date:  2012-08-01

3.  Total THA in adult osteonecrosis related to sickle cell disease.

Authors:  Philippe Hernigou; Sebastien Zilber; Paolo Filippini; Gilles Mathieu; Alexandre Poignard; Frederic Galacteros
Journal:  Clin Orthop Relat Res       Date:  2008-01-10       Impact factor: 4.176

Review 4.  Surgical management of osteonecrosis of the femoral head in patients with sickle cell disease.

Authors:  Atul F Kamath; Michael H McGraw; Craig L Israelite
Journal:  World J Orthop       Date:  2015-11-18

5.  Minimum ten-year follow-up of cemented total hip replacement in patients with osteonecrosis of the femoral head.

Authors:  Thomas M Fyda; John J Callaghan; Jason Olejniczak; Richard C Johnston
Journal:  Iowa Orthop J       Date:  2002

6.  Massive septic pelvic osteolysis following revision total hip arthroplasty in a patient with sickle cell anemia: clinical presentation and review of the literature.

Authors:  Panagiotis Korovessis; Thomas Repantis
Journal:  Eur J Orthop Surg Traumatol       Date:  2011-09-27

7.  Treatment of femoral head osteonecrosis in the United States: 16-year analysis of the Nationwide Inpatient Sample.

Authors:  Aaron J Johnson; Michael A Mont; Audrey K Tsao; Lynne C Jones
Journal:  Clin Orthop Relat Res       Date:  2014-02       Impact factor: 4.176

8.  Percutaneous implantation of autologous bone marrow osteoprogenitor cells as treatment of bone avascular necrosis related to sickle cell disease.

Authors:  Philippe Hernigou; Gilsasio Daltro; Paolo Filippini; Martin Mukisi Mukasa; Olivier Manicom
Journal:  Open Orthop J       Date:  2008-04-25

9.  Short term results of cementless total hip arthroplasty in sicklers.

Authors:  Yash Gulati; Mrinal Sharma; Bhupendra Bharti; Vibhu Bahl; Ishwar Bohra; Amit Goswani
Journal:  Indian J Orthop       Date:  2015 Jul-Aug       Impact factor: 1.251

10.  Sickle cell disease: management options and challenges in developing countries.

Authors:  Daniel Ansong; Alex Osei Akoto; Delaena Ocloo; Kwaku Ohene-Frempong
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-11-04       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.